Cargando…
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside
Systemic lupus erythematosus (SLE) is considered an autoimmune disease with multiorgan involvement. Many advances have been made during the last decade regarding inflammatory pathways, genetic and epigenetic alterations, adaptive and innate immune system mechanisms specifically involved in SLE patho...
Autores principales: | Squatrito, D., Emmi, G., Silvestri, E., Ciucciarelli, L., D’Elios, M. M., Prisco, D., Emmi, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389042/ https://www.ncbi.nlm.nih.gov/pubmed/26000154 http://dx.doi.org/10.1007/s13317-014-0058-y |
Ejemplares similares
-
An Approach to Differential Diagnosis of Antiphospholipid Antibody Syndrome and Related Conditions
por: Emmi, Giacomo, et al.
Publicado: (2014) -
Thrombosis in vasculitis: from pathogenesis to treatment
por: Emmi, Giacomo, et al.
Publicado: (2015) -
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease
por: Emmi, Giacomo, et al.
Publicado: (2016) -
Digital ulcers secondary to Sneddon’s syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis
por: Barnini, Tommaso, et al.
Publicado: (2012) -
Interleukin-17/Interleukin-21 and Interferon-γ producing T
cells specific for β2 Glycoprotein I in atherosclerosis inflammation of
systemic lupus erythematosus patients with antiphospholipid
syndrome
por: Benagiano, Marisa, et al.
Publicado: (2019)